Nucleolin has also been proposed as a marker to identify the circulating tumor cells of prostate cancer [58] and as a target for prostate cancer characterization by optical contrast-enhanced photoacoustic imaging using F3 peptide in nanoparticles [34]. The gene discussed is NUCLEOLIN; the disease is prostate carcinoma.